These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9181181)

  • 1. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study.
    Singh M; Saxena BB; Singh R; Kaplan J; Ledger WJ
    Adv Contracept; 1997 Mar; 13(1):1-11. PubMed ID: 9181181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres: phase II clinical study.
    Singh M; Saxena BB; Graver R; Ledger WJ
    Fertil Steril; 1989 Dec; 52(6):973-80. PubMed ID: 2591574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norethisterone contraceptive microspheres.
    Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
    J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive.
    Beck LR; Pope VZ; Flowers CE; Cowsar DR; Tice TR; Lewis DH; Dunn RL; Moore AB; Gilley RM
    Biol Reprod; 1983 Feb; 28(1):186-95. PubMed ID: 6830939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study.
    Grubb GS; Welch JD; Cole L; Goldsmith A; Rivera R
    Fertil Steril; 1989 May; 51(5):803-10. PubMed ID: 2523322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women.
    Singh M; Saxena BB; Raghubanshi RS; Ledger WJ; Harman SM; Leonard RJ
    Contraception; 1997 Jan; 55(1):23-33. PubMed ID: 9013058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of an improved injectable microcapsule contraceptive system.
    Beck LR; Flowers CE; Pope VZ; Wilborn WH; Tice TR
    Am J Obstet Gynecol; 1983 Dec; 147(7):815-21. PubMed ID: 6650605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of injectable biodegradable contraceptive system.
    Beck LR; Ramos RA; Flowers CE; Lopez GZ; Lewis DH; Cowsar DR
    Am J Obstet Gynecol; 1981 Aug; 140(7):799-806. PubMed ID: 7020421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting injectable norethisterone contraceptive system: review of clinical studies.
    Beck LR; Pope VZ
    Res Front Fertil Regul; 1984 Dec; 3(2):1-10. PubMed ID: 12179635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
    Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D
    Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S; Gaur LN; Saxena BN
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.